Table 1.
Clinical features and staging parameters
| Case number | Age (years) | Sex | Primary tumor site | T-size (cm) | N-size (cm) | Pathologic stage | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | 68 | Female | L tonsil | 2.5 | 3.5 | pT2N2b | Primary resection, Chemo-XRT, selective neck dissection and parapharyngeal node excision | Radiologic evidence of lung metastasis at 9 months; DOD at 27 months |
| 2 | 54 | Male | R base of tongue | – | 3.5 | pTxN2a | Primary Chemo-XRT and selective neck dissection | NED at 15 months |
| 3 | 55 | Male | L tonsil | 1.2 | 2.2 | pT2N2a | Primary resection, Chemo-XRT and a modified radical left neck dissection | Biopsy proven lung metastasis at 38 months; AWD (lung) at 59 months |
| 4 | 55 | Male | L tonsil | 0.4 | 3.2 | pT1N2a | Primary resection, neck dissection, and postoperative XRT | NED at 68 months |
| 5 | 55 | Male | Unknown | – | 3.0 | pTxN1 | Chemo-XRT | NED at 31 months |
| 6 | 64 | Male | Unknown | – | 4.7 | pTxN2a | XRT | <6 months F/U |
| 7 | 52 | Male | Unknown | – | 2.5 | pTxN1 | – | <6 months F/U |
L left, R right, T tumor, N (lymph) node, DOD dead of disease, XRT radiotherapy, NED no evidence of disease, AWD alive with disease, F/U follow-up, LTF lost to follow-up